CD33 expression and its association with gemtuzumab ozogamicin response: Results from the randomized phase III children's oncology group trial AAML0531

Jessica A. Pollard, Michael Loken, Robert B. Gerbing, Susana C. Raimondi, Betsy A. Hirsch, Richard Aplenc, Irwin D. Bernstein, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi

Research output: Contribution to journal › Article › peer-review

111 Scopus citations

Fingerprint

Dive into the research topics of 'CD33 expression and its association with gemtuzumab ozogamicin response: Results from the randomized phase III children's oncology group trial AAML0531'. Together they form a unique fingerprint.

Medicine & Life Sciences